Abstract:We previously reported F-18-labeled pyrazolo[1,5-a]pyrimidine derivatives: 7-(2-[F-18]fluoroethylamino)-5-methylpyrazolo[1,5-a]pyrimidine-3-carbonitrile ([F-18]1) and N-(2-(3-cyano-5-methylpyrazolo[1,5-a]pyrimidin-7-ylamino)ethyl)-2-[F-18]fluoro-4-nitro-benzamide ([F-18]2). Preliminary biodistribution experiments of both compounds showed s slow clearance rate from excretory tissues which warranted further investigation for tumor imaging with PET. Here we modified [F-18]1 and [F-18]2 by introducing polar groups such as ester, hydroxyl and carboxyl and developed three additional F-18-18 labeled pyrazolo[1,5-a] pyrimidine derivatives: (3-Cyano-7-(2-[F-18]fluoroethylamino)pyrazolo[1,5-a]-pyrimidin-5-yl) methyl acetate ([F-18]3), 7-(2-[F-18] fluoroethylamino)-5-(hydroxymethyl) pyrazolo[1,5-a]-pyrimidine-3-carbonitrile ([F-18]4) and (S)-6-(3-cyano-5-methylpyrazolo[1,5-a]pyrimidin-7-ylamino)- 2-(2-[F-18]fluoro-4-nitrobenzamido) hexanoic acid ([F-18]5). The radiolabeled probes were synthesized by nucleophilic substitution of the corresponding tosylate and nitro precursors with F-18-fluoride. In Vitro studies showed higher uptake of [F-18]3 and [F-18]4 than that of [F-18]5 by S180 tumor cells. In Vivo biodistribution studies in mice bearing S180 tumors showed that the uptake of both [F-18]3 and [F-18] in tumors displayed an increasing trend while the uptake of [F-18]5 in tumor decreased through the course of the 120 min study. This significant difference in tumor uptake was also found between [F-18]1 and [F-18]2. Thus, we compared the biological behavior of the five tracers and reported the tumor uptake kinetic differences between 2-[F-18]fluoroethylamino- and 2-[F-18]fluoro-4-nitro- benzamidopyrazolo[1,5-a] pyrimidine derivatives.

Synthesis and Biological Evaluation of Pyrazolo[1,5-a]-pyrimidine-containing 99mTc Nitrido Radiopharmaceuticals as Imaging Agents for Tumors

Synthesis And Biological Evaluation Of Pyrazolo[1,5-A]-Pyrimidine-Containing Tc-99m Nitrido Radiopharmaceuticals As Imaging Agents For Tumors

Preparation and bioevaluation of 99m Tc nitrido radiopharmaceuticals with pyrazolo[1,5-a]pyrimidine as tumor imaging agents

18F-labeled Pyrazolo[1,5-a]pyrimidine Derivatives: Synthesis from 2,4-Dinitrobenzamide and Tosylate Precursors and Comparative Biological Evaluation for Tumor Imaging with Positron Emission Tomography

Synthesis and Biodistribution of 99Mtc-Peptides Conjugated Adenine As Tumor Imaging Agents

Radiolabeling and Biological Evaluation of Novel 99Mtc-Nitrido and 99Mtc-Oxo Complexes with 4-Methoxy-l-phenylalanine Dithiocarbamate for Tumor Imaging.

Synthesis and Biodistribution of 99Tcm-MAG2-Ade as A Tumor Imaging Agent

Synthesis and Evaluation of 99Mtc–2-[(3-carboxy-1-oxopropyl)amino]-2-deoxy-d-glucose As a Potential Tumor Imaging Agent

Synthesis, radiolabeling and biodistribution studies of [<sup>99m</sup>Tc(CO)<sub>3</sub>(MN-TZ-BPA)]<sup>+</sup> in tumor-bearing mice

Synthesis, Radiolabeling And Biodistribution Studies Of [Tc-99m(Co)(3)(Mn-Tz-Bpa)](+) In Tumor-Bearing Mice

Synthesis, radiolabeling and biodistribution studies of [ 99m Tc(CO) 3 (MN-TZ-BPA)] + in tumor-bearing mice

Synthesis and Biodistribution of a Novel 99mtc Nitrido Radiopharmaceutical with Proline Dithiocarbamate As a Potential Tumor Imaging Agent

Novel [99mtcn]2+ Labeled EGFR Inhibitors As Potential Radiotracers for Single Photon Emission Computed Tomography (SPECT) Tumor Imaging

Synthesis and biological evaluation of novel 99mTc‐oxo and 99mTc‐tricarbonyl complexes with C3′‐functionalized thymidine dithiocarbamate for tumor imaging

Synthesis and Biological Evaluation of Novel 99Mtc(co)3-Labeled Thymidine Analogs As Potential Probes for Tumor Proliferation Imaging

Synthesis and Biological Evaluation of Novel 99m Tc-oxo and 99m Tc-nitrido Complexes with Phenylalanine Dithiocarbamate for Tumor Imaging

F-18-Labeled Pyrazolo[1,5-A]Pyrimidine Derivatives: Synthesis From 2,4-Dinitrobenzamide And Tosylate Precursors And Comparative Biological Evaluation For Tumor Imaging With Positron Emission Tomography

Synthesis and Biological Evaluation of 7-(2-chlorophenylamino)-5-((2- [18F]fluoro-Ethyoxy)methyl)pyrazolo[1,5-a]pyrimidine-3-carbonitrile As PET Tumor Imaging Agent

Synthesis, Biodistribution and Quantitative Structure-Activity Relationship Studies of New 99mtc Labeled Pseudo-Peptide Complexes.

Synthesis and Biological Evaluation of a Novel (99m)tc Nitrido Radiopharmaceutical with Deoxyglucose Dithiocarbamate, Showing Tumor Uptake.

Novel 99m Tc-labelled complexes with thymidine isocyanide: radiosynthesis and evaluation as potential tumor imaging tracers.